title: Liver disease progression and virological response: entecavir rescue still possible in the setting of rtM204I lamivudine-resistant mutation.
authors.forename: Poh Seng
authors.initials: PS
authors.lastname: Tan
authors.forename: Myat Oo
authors.initials: MO
authors.lastname: Aung
authors.forename: Yock Young
authors.initials: YY
authors.lastname: Dan
authors.forename: Yin Mei
authors.initials: YM
authors.lastname: Lee
authors.forename: Kieron
authors.initials: K
authors.lastname: Lim
authors.forename: How Cheng
authors.initials: HC
authors.lastname: Low
authors.forename: Guan Huei
authors.initials: GH
authors.lastname: Lee
authors.forename: Maung Aye
authors.initials: MA
authors.lastname: Thwin
authors.forename: Charlene
authors.initials: C
authors.lastname: Soon
authors.forename: Seng Gee
authors.initials: SG
authors.lastname: Lim
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents; C413685:entecavir; D006147:Guanine